Jichu yixue yu linchuang (Aug 2022)

Research progress on the effects of mineralocorticoid receptor on cardiovascular diseases

  • MA Qian-yu, PENG Shi, ZHANG Zhao-yuan, ZHANG Dan, ZHANG Jin

DOI
https://doi.org/10.16352/j.issn.1001-6325.2022.08.1292
Journal volume & issue
Vol. 42, no. 8
pp. 1292 – 1296

Abstract

Read online

The mineralocorticoid receptor (MR) is a ligand-activated cytoplasmic receptor.Activation of MR in different cells can cause cardiovascular inflammation, oxidative stress, tissue remodeling ,and even function change the activity of ion channels resulting in incidence of arrhythmia through various mechanisms.MR antagonists are effective medicine to treat hypertension,coronary heart disease,and heart failure. In addition, the role of MR in arrhythmia and pulmonary hypertension also provides new perspectives for future clinical medication.

Keywords